3.6.0.2 html 451 495 1 false 151 0 false 12 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Operations Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/StatementConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncomeLossParenthetical Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) Statements 6 false false R7.htm 100060 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 7 false false R8.htm 100070 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical Consolidated Statements of Stockholders' Equity (Parenthetical) Statements 8 false false R9.htm 100080 - Statement - Consolidated Statements of Cash Flows Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 9 false false R10.htm 100090 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureVALUATIONANDQUALIFYINGACCOUNTS VALUATION AND QUALIFYING ACCOUNTS Notes 10 false false R11.htm 100100 - Disclosure - Nature of Operations and Business Activities Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureNatureOfOperationsAndBusinessActivities Nature of Operations and Business Activities Notes 11 false false R12.htm 100110 - Disclosure - Liquidity and Going Concern Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureLiquidityAndGoingConcern Liquidity and Going Concern Notes 12 false false R13.htm 100120 - Disclosure - Significant Accounting Policies Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSignificantAccountingPolicies Significant Accounting Policies Notes 13 false false R14.htm 100130 - Disclosure - Acquisitions Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureAcquisitions Acquisitions Notes 14 false false R15.htm 100140 - Disclosure - Fair Value Measurements Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 100150 - Disclosure - Marketable Securities Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureMarketableSecurities Marketable Securities Notes 16 false false R17.htm 100160 - Disclosure - Property and Equipment Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosurePropertyAndEquipment Property and Equipment Notes 17 false false R18.htm 100170 - Disclosure - Investments in Common Stock Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureInvestmentsInCommonStock Investments in Common Stock Notes 18 false false R19.htm 100180 - Disclosure - Equity Method Investments Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureEquityMethodInvestments Equity Method Investments Notes 19 false false R20.htm 100190 - Disclosure - Goodwill and Intangible Assets Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 20 false false R21.htm 100200 - Disclosure - Significant Agreements and Contracts Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSignificantAgreementsAndContracts Significant Agreements and Contracts Notes 21 false false R22.htm 100210 - Disclosure - Loan and Security Agreement Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureLoanAndSecurityAgreement Loan and Security Agreement Notes 22 false false R23.htm 100220 - Disclosure - Stockholders' Equity Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureStockholdersEquity Stockholders' Equity Notes 23 false false R24.htm 100230 - Disclosure - Derivative Liability Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureDerivativeLiability Derivative Liability Notes 24 false false R25.htm 100240 - Disclosure - Commitments and Contingencies Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 100250 - Disclosure - Income Taxes Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 26 false false R27.htm 100260 - Disclosure - Related Party Agreements and Other Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureRelatedPartyAgreementsAndOther Related Party Agreements and Other Notes 27 false false R28.htm 100270 - Disclosure - 401(k) Plan Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/Disclosure401KPlan 401(k) Plan Notes 28 false false R29.htm 100280 - Disclosure - Quarterly Financial Data (Unaudited) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureQuarterlyFinancialDataUnaudited Quarterly Financial Data (Unaudited) Notes 29 false false R30.htm 100290 - Disclosure - Subsequent Events Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 30 false false R31.htm 100300 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSignificantAccountingPolicies 31 false false R32.htm 100310 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSignificantAccountingPolicies 32 false false R33.htm 100320 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureFairValueMeasurements 33 false false R34.htm 100330 - Disclosure - Marketable Securities (Tables) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureMarketableSecuritiesTables Marketable Securities (Tables) Tables http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureMarketableSecurities 34 false false R35.htm 100340 - Disclosure - Property and Equipment (Tables) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) Tables http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosurePropertyAndEquipment 35 false false R36.htm 100350 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssets 36 false false R37.htm 100360 - Disclosure - Loan and Security Agreement (Tables) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureLoanAndSecurityAgreementTables Loan and Security Agreement (Tables) Tables http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureLoanAndSecurityAgreement 37 false false R38.htm 100370 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureStockholdersEquity 38 false false R39.htm 100380 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureCommitmentsAndContingencies 39 false false R40.htm 100390 - Disclosure - Income Taxes (Tables) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureIncomeTaxes 40 false false R41.htm 100400 - Disclosure - Quarterly Financial Data (Unaudited) (Tables) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureQuarterlyFinancialDataUnauditedTables Quarterly Financial Data (Unaudited) (Tables) Tables http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureQuarterlyFinancialDataUnaudited 41 false false R42.htm 100410 - Disclosure - Valuation and Qualifying Accounts (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureValuationAndQualifyingAccountsDetail Valuation and Qualifying Accounts (Detail) Details 42 false false R43.htm 100420 - Disclosure - Nature of Operations and Business Activities - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureNatureOfOperationsAndBusinessActivitiesAdditionalInformationDetail Nature of Operations and Business Activities - Additional Information (Detail) Details 43 false false R44.htm 100430 - Disclosure - Liquidity and Going Concern - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureLiquidityAndGoingConcernAdditionalInformationDetail Liquidity and Going Concern - Additional Information (Detail) Details 44 false false R45.htm 100440 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetail Significant Accounting Policies - Additional Information (Detail) Details 45 false false R46.htm 100450 - Disclosure - Significant Accounting Policies - Components of Outstanding Securities (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSignificantAccountingPoliciesComponentsOfOutstandingSecuritiesDetail Significant Accounting Policies - Components of Outstanding Securities (Detail) Details 46 false false R47.htm 100460 - Disclosure - Acquisitions - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail Acquisitions - Additional Information (Detail) Details 47 false false R48.htm 100470 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Details 48 false false R49.htm 100480 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 49 false false R50.htm 100490 - Disclosure - Fair Value Measurements - Summary of Contingent Consideration Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfContingentConsiderationLiabilitiesMeasuredAtFairValueUsingSignificantUnobservableInputsLevel3Detail Fair Value Measurements - Summary of Contingent Consideration Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) Details 50 false false R51.htm 100500 - Disclosure - Fair Value Measurements - Summary of Derivative Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfDerivativeLiabilitiesMeasuredAtFairValueUsingSignificantUnobservableInputsLevel3Detail Fair Value Measurements - Summary of Derivative Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) Details 51 false false R52.htm 100510 - Disclosure - Fair Value Measurements - Summary of Quantitative Information about Inputs and Valuation Methodologies used for Fair Value Measurements Classified in Level 3 (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfQuantitativeInformationAboutInputsAndValuationMethodologiesUsedForFairValueMeasurementsClassifiedInLevel3Detail Fair Value Measurements - Summary of Quantitative Information about Inputs and Valuation Methodologies used for Fair Value Measurements Classified in Level 3 (Detail) Details 52 false false R53.htm 100520 - Disclosure - Fair Value Measurements - Schedule of Carrying Value and Fair Value of Notes Receivable and Debt Obligations (Detail) Notes http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfCarryingValueAndFairValueOfNotesReceivableAndDebtObligationsDetail Fair Value Measurements - Schedule of Carrying Value and Fair Value of Notes Receivable and Debt Obligations (Detail) Details 53 false false R54.htm 100530 - Disclosure - Marketable Securities - Schedule of Marketable Securities (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetail Marketable Securities - Schedule of Marketable Securities (Detail) Details 54 false false R55.htm 100540 - Disclosure - Marketable Securities - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetail Marketable Securities - Additional Information (Detail) Details 55 false false R56.htm 100550 - Disclosure - Summary of Warrant Measured at Fair Value Using Significant Unobservable Inputs (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSummaryOfWarrantMeasuredAtFairValueUsingSignificantUnobservableInputsDetail Summary of Warrant Measured at Fair Value Using Significant Unobservable Inputs (Detail) Details 56 false false R57.htm 100560 - Disclosure - Property and Equipment - Summary of Property and Equipment (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetail Property and Equipment - Summary of Property and Equipment (Detail) Details 57 false false R58.htm 100570 - Disclosure - Property and Equipment - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail Property and Equipment - Additional Information (Detail) Details 58 false false R59.htm 100580 - Disclosure - Investments in Common Stock - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureInvestmentsInCommonStockAdditionalInformationDetail Investments in Common Stock - Additional Information (Detail) Details 59 false false R60.htm 100590 - Disclosure - Equity Method Investments - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureEquityMethodInvestmentsAdditionalInformationDetail Equity Method Investments - Additional Information (Detail) Details 60 false false R61.htm 100600 - Disclosure - Goodwill and Intangible Assets - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetail Goodwill and Intangible Assets - Additional Information (Detail) Details 61 false false R62.htm 100610 - Disclosure - Goodwill and Intangible Assets - Summary of Changes in Company's Recorded Goodwill (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfChangesInCompanySRecordedGoodwillDetail Goodwill and Intangible Assets - Summary of Changes in Company's Recorded Goodwill (Detail) Details 62 false false R63.htm 100620 - Disclosure - Goodwill and Intangible Assets - Summary of Company's Identifiable Intangible Assets (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfCompanySIdentifiableIntangibleAssetsDetail Goodwill and Intangible Assets - Summary of Company's Identifiable Intangible Assets (Detail) Details 63 false false R64.htm 100630 - Disclosure - Goodwill and Intangible Assets - Schedule of Estimated Future Amortization Expense Related to Intangible Assets (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfEstimatedFutureAmortizationExpenseRelatedToIntangibleAssetsDetail Goodwill and Intangible Assets - Schedule of Estimated Future Amortization Expense Related to Intangible Assets (Detail) Details 64 false false R65.htm 100640 - Disclosure - Significant Agreements and Contracts - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSignificantAgreementsAndContractsAdditionalInformationDetail Significant Agreements and Contracts - Additional Information (Detail) Details 65 false false R66.htm 100650 - Disclosure - Loan and Security Agreement - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureLoanAndSecurityAgreementAdditionalInformationDetail Loan and Security Agreement - Additional Information (Detail) Details 66 false false R67.htm 100660 - Disclosure - Loan and Security Agreement - Schedule of Long-Term Debt and Unamortized Discount Balances (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureLoanAndSecurityAgreementScheduleOfLongTermDebtAndUnamortizedDiscountBalancesDetail Loan and Security Agreement - Schedule of Long-Term Debt and Unamortized Discount Balances (Detail) Details 67 false false R68.htm 100670 - Disclosure - Loan and Security Agreement - Future Minimum Payments under the Loan and Security Agreement (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureLoanAndSecurityAgreementFutureMinimumPaymentsUnderLoanAndSecurityAgreementDetail Loan and Security Agreement - Future Minimum Payments under the Loan and Security Agreement (Detail) Details 68 false false R69.htm 100680 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 69 false false R70.htm 100690 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail Stockholders' Equity - Summary of Stock Option Activity (Detail) Details 70 false false R71.htm 100700 - Disclosure - Stockholders' Equity - Fair Value of Employee Stock Options (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetail Stockholders' Equity - Fair Value of Employee Stock Options (Detail) Details 71 false false R72.htm 100710 - Disclosure - Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetail Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Detail) Details 72 false false R73.htm 100720 - Disclosure - Derivative Liability - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail Derivative Liability - Additional Information (Detail) Details 73 false false R74.htm 100730 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 74 false false R75.htm 100740 - Disclosure - Commitments and Contingencies - Summary of Minimum Future Non-Cancelable Annual Operating Lease Obligations (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfMinimumFutureNonCancelableAnnualOperatingLeaseObligationsDetail Commitments and Contingencies - Summary of Minimum Future Non-Cancelable Annual Operating Lease Obligations (Detail) Details 75 false false R76.htm 100750 - Disclosure - Income Taxes - Schedule of Components of Provision Expense (Benefit) (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionExpenseBenefitDetail Income Taxes - Schedule of Components of Provision Expense (Benefit) (Detail) Details 76 false false R77.htm 100760 - Disclosure - Income Taxes - Summary of Components of Net Deferred Tax Liabilities and Related Valuation Allowance(Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfNetDeferredTaxLiabilitiesAndRelatedValuationAllowanceDetail Income Taxes - Summary of Components of Net Deferred Tax Liabilities and Related Valuation Allowance(Detail) Details 77 false false R78.htm 100770 - Disclosure - Income Taxes - Summary of Reconciliation Between Federal Income Tax and Company Provision for Income Taxes (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationBetweenFederalIncomeTaxAndCompanyProvisionForIncomeTaxesDetail Income Taxes - Summary of Reconciliation Between Federal Income Tax and Company Provision for Income Taxes (Detail) Details 78 false false R79.htm 100780 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 79 false false R80.htm 100790 - Disclosure - Income Taxes - Summary of Reconciliation of Unrecognized Tax Expense (Benefits) (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxExpenseBenefitsDetail Income Taxes - Summary of Reconciliation of Unrecognized Tax Expense (Benefits) (Detail) Details 80 false false R81.htm 100800 - Disclosure - Related Party Agreements and Other - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureRelatedPartyAgreementsAndOtherAdditionalInformationDetail Related Party Agreements and Other - Additional Information (Detail) Details 81 false false R82.htm 100810 - Disclosure - 401(k) Plan - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/Disclosure401KPlanAdditionalInformationDetail 401(k) Plan - Additional Information (Detail) Details 82 false false R83.htm 100820 - Disclosure - Quarterly Financial Data (Unaudited) - Schedule of Quarterly Financial Data (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureQuarterlyFinancialDataUnauditedScheduleOfQuarterlyFinancialDataDetail Quarterly Financial Data (Unaudited) - Schedule of Quarterly Financial Data (Detail) Details http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureQuarterlyFinancialDataUnauditedTables 83 false false R84.htm 100830 - Disclosure - Quarterly Financial Data (Unaudited) - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureQuarterlyFinancialDataUnauditedAdditionalInformationDetail Quarterly Financial Data (Unaudited) - Additional Information (Detail) Details http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureQuarterlyFinancialDataUnauditedTables 84 false false R85.htm 100840 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.sorrentotherapeutics.com/20161231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail Subsequent Events - Additional Information (Detail) Details 85 false false All Reports Book All Reports srne-20161231.xml srne-20161231.xsd srne-20161231_cal.xml srne-20161231_def.xml srne-20161231_lab.xml srne-20161231_pre.xml true true